Bone remodeling markers in the detection of bone metastases in prostate cancer
- 15 March 2003
- journal article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 331 (1-2) , 45-53
- https://doi.org/10.1016/s0009-8981(03)00081-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- PYRIDINOLINE CROSS-LINKED CARBOXYTERMINAL TELOPEPTIDE OF TYPE I COLLAGEN AS A USEFUL MARKER FOR MONITORING METASTATIC BONE ACTIVITY IN MEN WITH PROSTATE CANCERJournal of Urology, 2001
- Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin KBone, 2000
- Biochemical markers of bone formation in the study of postmenopausal osteoporosisOsteoporosis International, 1998
- Skeletal complications of malignancyCancer, 1997
- Characterization of Urinary Degradation Products Derived from Type I CollagenJournal of Biological Chemistry, 1997
- Clinical Efficacy of Bone Alkaline Phosphatase and Prostate Specific Antigen in the Diagnosis of Bone Metastasis in Prostate CancerJournal of Urology, 1996
- Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone diseaseJournal of Clinical Endocrinology & Metabolism, 1993
- A reappraisal of serial isotope bone scans in prostate cancerThe British Journal of Radiology, 1993
- A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urineJournal of Bone and Mineral Research, 1992
- Prostate Specific Antigen and Bone Scan Correlation in the Staging and Monitoring of Patients with Prostatic CancerPublished by Wiley ,1992